Downregulation of DYRK2 can be a predictor of recurrence in early stage breast cancer

DYRK2 controls the epithelial–mesenchymal transition in breast cancer by degrading Snail

(2013) Rei Mimoto et al.   CANCER LETTERS

Dyrk2-associated EDD-DDB1-VprBP E3 Ligase Inhibits Telomerase by TERT Degradation

(2013) Hae-Yun Jung et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

DYRK2 priming phosphorylation of c-Jun and c-Myc modulates cell cycle progression in human cancer cells

(2012) Naoe Taira et al.   JOURNAL OF CLINICAL INVESTIGATION

Mutual regulation between SIAH2 and DYRK2 controls hypoxic and genotoxic signaling pathways

(2012) Moisés Pérez et al.   Journal of Molecular Cell Biology

Gene-expression-based prognostic assays for breast cancer

(2010) Chungyeul Kim et al.   Nature Reviews Clinical Oncology

Expression of dual-specificity tyrosine-(Y)-phosphorylation–regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma

(2009) Shin-ichi Yamashita et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Role for DYRK family kinases on regulation of apoptosis

(2008) Kiyotsugu Yoshida   BIOCHEMICAL PHARMACOLOGY